Recombinant Human Annexin A1 is produced by our E.coli expression system and the target gene encoding Ala2-Asn346 is expressed.
Less than 0.1 ng/µg (1 IEU/µg) as determined by LAL test.
Estimated molecular weight
Lyophilized from a 0.2 µm filtered solution of 20mM PB, 150mM NaCl, pH 7.2.
Greater than 95% as determined by reducing SDS-PAGE.
Always centrifuge tubes before opening. Do not mix by vortex or pipetting.It is not recommended to reconstitute to a concentration less than 100 µg/ml.Dissolve the lyophilized protein in ddH2O.Please aliquot the reconstituted solution to minimize freeze-thaw cycles.
This Annexin V calcium dependent phospholipid binding protein will be downstream of BCL2 pathway and at caspase apoptotic level. novo has more cell death kits and antibodies.
Human proteins, cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies. Modern humans (Homo sapiens, primarily ssp. Homo sapiens sapiens). Depending on the epitopes used human ELISA kits can be cross reactive to many other species. Mainly analyzed are human serum, plasma, urine, saliva, human cell culture supernatants and biological samples.
Recombinants or rec. proteins
Recombinant Annexin A1/ANXA1
recombinant H. sapiens Annexin A1/annexin A1
Alternative to gene target
annexin A1, ANX1 and LPC1, ANXA1 and IDBG-71054 and ENSG00000135046 and 301, protein binding, nuclei, Anxa1 and IDBG-151723 and ENSMUSG00000024659 and 16952, BT.70631 and IDBG-632306 and ENSBTAG00000015978 and 327662